Helix BioPharma Corp Buy Hold or Sell Recommendation
| HBPCFDelisted Stock | USD 0.15 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Helix BioPharma Corp is 'Not Rated'. Macroaxis provides Helix BioPharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding HBPCF positions. The advice algorithm takes into account all of Helix BioPharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Helix BioPharma's buy or sell advice are summarized below:
Real Value 0.13 | Hype Value 0.15 | Market Value 0.15 | Naive Value 0.15 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Helix BioPharma Corp given historical horizon and risk tolerance towards Helix BioPharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Helix BioPharma Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Helix |
Execute Helix BioPharma Buy or Sell Advice
The Helix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Helix BioPharma Corp. Macroaxis does not own or have any residual interests in Helix BioPharma Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Helix BioPharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Helix BioPharma Trading Alerts and Improvement Suggestions
| Helix BioPharma Corp is not yet fully synchronised with the market data | |
| Helix BioPharma Corp has some characteristics of a very speculative penny stock | |
| Helix BioPharma Corp has a very high chance of going through financial distress in the upcoming years | |
| The company has accumulated 2.88 M in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Helix BioPharma Corp has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Helix BioPharma until it has trouble settling it off, either with new capital or with free cash flow. So, Helix BioPharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Helix BioPharma Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Helix to invest in growth at high rates of return. When we think about Helix BioPharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Helix BioPharma Corp has accumulated about 1.88 M in cash with (6.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 18.0% of Helix BioPharma shares are held by company insiders |
Helix BioPharma current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Helix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Helix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Helix BioPharma Returns Distribution Density
The distribution of Helix BioPharma's historical returns is an attempt to chart the uncertainty of Helix BioPharma's future price movements. The chart of the probability distribution of Helix BioPharma daily returns describes the distribution of returns around its average expected value. We use Helix BioPharma Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Helix BioPharma returns is essential to provide solid investment advice for Helix BioPharma.
| Mean Return | -0.09 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 0.77 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Helix BioPharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Helix BioPharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Helix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Helix BioPharma Buy or Sell Advice
When is the right time to buy or sell Helix BioPharma Corp? Buying financial instruments such as Helix Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Helix BioPharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sport Products Thematic Idea Now
Sport Products
Companies manufacturing sporting goods and accessories. The Sport Products theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Helix BioPharma Corp information on this page should be used as a complementary analysis to other Helix BioPharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Helix Pink Sheet
If you are still planning to invest in Helix BioPharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Helix BioPharma's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |